Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder

Part of paid clinical trials in San Francisco, California.

Sponsor
University of California, San Francisco
Study ID
NCT06518785
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Low Intensity Focused Ultrasound — DEVICE
    An inhibitory LIFU protocol that allows suppression of neuronal activity in the basal ganglia and thalamus will be used.

Study Details

This study aims to examine the effects of Low-Intensity Focused Ultrasound (LIFU) on brain activity in patients with alcohol use disorder.

Key Dates

Start date
Jan 7, 2025
Status verified
Aug 2025
Primary completion
Sep 30, 2030
Completion
Sep 30, 2030

Study Design

Enrollment
25 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE

Arms

  • Experimental: VS LIFU/ VPL LIFU
    Participants will be assigned to receive VS LIFU during the first LIFU treatment session.
  • Active Comparator: VPL LIFU/VS LIFU
    Participants will be assigned to receive VPL LIFU during the first LIFU treatment session.

Primary Outcome Measure

Incidence of LIFU-related adverse events. [ Time Frame: Through study completion, an average of 5 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of California, San FranciscoSan FranciscoCalifornia94143
Catherine Borror, BS, CCRP
[email protected]
415-514-6551
Sierra Brandts, BS
[email protected]
415-514-6551
Khaled Moussawi, MD, PhD (PRINCIPAL_INVESTIGATOR)
Andrew Kayser, MD, PhD (SUB_INVESTIGATOR)

Find similar trials in San Francisco, CA

By condition
Substance use disorder
By specialty
Behavioral healthAddiction medicine
By research site
University of California, San Francisco· San Francisco, CA

Related Studies